Skip to Main Content Skip to Main Content

HSC Medicine, Dentistry and Healthcare Sciences Current Awareness Bulletins: Healthcare Science

Healthcare Science current awareness bulletin

Frequency: Bi-monthly

Links to articles in the current and previous 2 issues of this bulletin are displayed below.

To receive email notifications about new issues of this bulletin, please email:

June 2024

Advanced 3D imaging and organoid bioprinting for biomedical research and therapeutic applications 10.1016/j.addr.2024.115237

Best practices and recommendations for grossing and reporting of post-immunotherapy nephrectomy specimens: a single-institution experience of 70 cases 10.1016/j.mpdhp.2024.02.002

The bisulfite reaction with cytosine and genomic DNA structure 10.1016/j.ab.2024.115532

Cell membrane-coated nanoparticles for targeting carcinogenic bacteria 10.1016/j.addr.2024.115320

Challenges and progress related to gene editing in rare skin diseases 10.1016/j.addr.2024.115294

Clinical relevance and advances in detection of translational biomarker cardiac troponin 10.1016/j.ab.2024.115505

COVID-19 electrochemical immunosensor with Ag-MOF: rapid and high-selectivity nasal swab testing for effective detection 10.1016/j.ab.2024.115500

From cells to subcellular organelles: next-generation cancer therapy based on peptide self-assembly 10.1016/j.addr.2024.115327

Identification of volatile biomarkers for lung cancer from different histological sources: a comprehensive study 10.1016/j.ab.2024.115527

Microscopic colitis: what's in a name? An overview from clinical and histological perspectives 10.1016/j.mpdhp.2024.01.001

Molecular uropathology: what a practising pathologist should know 10.1016/j.mpdhp.2024.02.003

The morphomolecular features of cholangiocarcinoma in the personalised era 10.1016/j.mpdhp.2024.01.004

A new era of targeting cystic fibrosis with non-viral delivery of genomic medicines 10.1016/j.addr.2024.115305

Non-viral delivery of RNA for therapeutic T cell engineering 10.1016/j.addr.2024.115215

Prolidase activity assays. A survey of the reported literature methodologies 10.1016/j.ab.2024.115506

Recent advances of focused ultrasound induced blood-brain barrier opening for clinical applications of neurodegenerative diseases 10.1016/j.addr.2024.115323

Research progress on prediction of RNA-protein binding sites in the past five years 10.1016/j.ab.2024.115535

Testicular germ cell tumors: challenges in tumor diagnosis and pathological staging 10.1016/j.mpdhp.2024.02.004


Advanced Drug Delivery Reviews (May-Jun); Analytical Biochemistry (Jun-Aug); Diagnostic Histopathology (Apr-May)

April 2024

AcousticRobots: smart acoustically powered micro-/nanoswimmers for precise biomedical applications 10.1016/j.addr.2024.115201

Antimicrobial, antioxidant, cell imaging and sensing applications of fluorescein derivatives: A review 10.1016/j.ab.2024.115479

Beyond the adverse effects of the systemic route: Exploiting nanocarriers for the topical treatment of skin cancers 10.1016/j.addr.2024.115197

Differential diagnosis of sinonasal tumours with emphasis given to undifferentiated malignancy, spindle cell lesions and tumours with divergent differentiation 10.1016/j.mpdhp.2023.12.002

Emerging strategies for nanomedicine in autoimmunity 10.1016/j.addr.2024.115194

From concept to early clinical trials: 30 years of microbubble-based ultrasound-mediated drug delivery research 10.1016/j.addr.2024.115199

Human stem cell-based embryo models (UK Parliamentary Office of Science and Technology research briefing, 29th February 2024)

The immunostimulatory nature of mRNA lipid nanoparticles 10.1016/j.addr.2023.115175

An insight into the state of nanotechnology-based electrochemical biosensors for PCOS detection 10.1016/j.ab.2023.115412

Invasive breast cancer reporting guidelines: ICCR, CAP, RCPath, RCPA datasets and future directions 10.1016/j.mpdhp.2023.11.001

mRNA delivery systems for cancer immunotherapy: Lipid nanoparticles and beyond 10.1016/j.addr.2024.115190

Nanoscale contrast agents: A promising tool for ultrasound imaging and therapy 10.1016/j.addr.2024.115200

An overview of B coding of breast core biopsy categorisation and management implications 10.1016/j.mpdhp.2023.11.004

Overview of the different methods for RNA preparation in COVID-19 diagnosis process during the pandemic 10.1016/j.ab.2023.115410

Revealing the clinical potential of high-resolution organoids 10.1016/j.addr.2024.115202

Review of immune checkpoint blockade and PD-L1 testing in breast cancer 10.1016/j.mpdhp.2023.12.001

Translation of cell therapies to treat autoimmune disorders 10.1016/j.addr.2023.115161

Ultrasound-responsive microbubbles and nanodroplets: A pathway to targeted drug delivery 10.1016/j.addr.2023.115178

Unlocking the mitochondria for nanomedicine-based treatments: overcoming biological barriers, improving designs, and selecting verification techniques 10.1016/j.addr.2024.115195


Advanced Drug Delivery Reviews (Feb-Apr); Analytical Biochemistry (Mar-May); Diagnostic Histopathology (Feb-Mar); Parliamentary Office of Science and Technology [POST] website (Feb)

February 2024

Anogenital lichenoid lesions: clinicopathological features and differential diagnosis DOI: 10.1016/j.mpdhp.2023.10.004

Engineering metabolism to modulate immunity DOI: 10.1016/j.addr.2023.115122

Estimates of early outbreak-specific SARS-CoV-2 epidemiological parameters from genomic data DOI: 10.1073/pnas.230812512

Expanded T lymphocytes in the cerebrospinal fluid of multiple sclerosis patients are specific for Epstein-Barr-virus-infected B cells DOI: 10.1073/pnas.231585712

Exploratory study on micronuclei and metanuclear abnormalities in exfoliated buccal cells of COVID-19 suspected patients DOI: 10.4103/joc.joc_53_23

A framework for standardised tissue sampling and processing during resection of diffuse intracranial glioma: joint recommendations from four RANO groups DOI: 10.1016/S1470-2045(23)00453-9

In situ cellular hitchhiking of nanoparticles for drug delivery DOI: 10.1016/j.addr.2023.115143

Liquid-based cervical cytology: monitoring the laboratory quality indicators DOI: 10.4103/joc.joc_112_23

Mucormycosis: cytomorphological spectrum in fine-needle aspiration cytology DOI: 10.4103/joc.joc_107_23  

Multiscale spatial mapping of cell populations across anatomical sites in healthy human skin and basal cell carcinoma DOI: 10.1073/pnas.2313326120

A potential biomarker of radiosensitivity in metastatic hormone sensitive prostate cancer patients treated with combination external beam radiotherapy and radium-223 DOI: 10.1016/j.radonc.2023.110063

Rapid single-particle chemical imaging of nanoplastics by SRS microscopy DOI: 10.1073/pnas.2300582121

Recent progress in MoS2 nanostructures for biomedical applications: Experimental and computational approach DOI: 10.1016/j.ab.2023.115404

Renal tumours of childhood: what's new in classification, morphology, molecular findings and prognosis DOI: 10.1016/j.mpdhp.2023.09.003

Type 1 diabetes in the pancreas: A histological perspective DOI: 10.1111/dme.15228

Value of imprint cytology for the rapid diagnosis of mucormycosis in the COVID-19 pandemic setting – a pilot study DOI: 10.4103/joc.joc_81_22

What can functional brain imaging teach us about remission of type 2 diabetes? DOI: 10.1111/dme.15235

Sources used: Advanced Drug Delivery Reviews (Jan); Analytical Biochemistry (Jan); Diabetic Medicine (Dec); Diagnostic Histopathology (Dec, Jan); Journal of Cytology (Jan); Lancet Oncology, The (Nov); PNAS (Jan); Radiotherapy and Oncology (Dec)